Newsroom
Saniona Icon blue
Latest News
August 5, 2022
PRESS RELEASE August 5 , 202 2 Saniona (OMX: SANION), a clinical stage biopharmaceutical company, today announced that 6,45 0, 734 options have forfeited in 20 22, leading to a reduction in potential dilution from 11.89% to 3.0 6 %. As of December 31, 2021, the company had 8,402,181 options
July 15, 2022
PRESS RELEASE 15 July 202 2 The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the English translation, the Swedish text shall prevail. The shareholders in Saniona AB, Reg. No. 556962-5345, are hereby invited to attend the extraordinary general
July 6, 2022
PRESS RELEASE Ju ly 6 , 202 2 Saniona (OMX: SANION), a clinical stage biopharmaceutical company, today announced that the CEO and a member of the B oard of Directors have purchased 2 4 0 ,221 shares of the company in the open market for a total value of approximately SEK 0 . 9 million .
If you have any questions regarding Saniona's media communication, feel free to contact us at any time.
thomas feldthus
Thomas Feldthus, co-founder and CEO Email: investor@saniona.com